Your browser doesn't support javascript.
loading
Performance of the inFLUenza Patient-Reported Outcome (FLU-PRO) diary in patients with influenza-like illness (ILI).
Powers, John H; Bacci, Elizabeth D; Leidy, Nancy K; Poon, Jiat-Ling; Stringer, Sonja; Memoli, Matthew J; Han, Alison; Fairchok, Mary P; Coles, Christian; Owens, Jackie; Chen, Wei-Ju; Arnold, John C; Danaher, Patrick J; Lalani, Tahaniyat; Burgess, Timothy H; Millar, Eugene V; Ridore, Michelande; Hernández, Andrés; Rodríguez-Zulueta, Patricia; Ortega-Gallegos, Hilda; Galindo-Fraga, Arturo; Ruiz-Palacios, Guillermo M; Pett, Sarah; Fischer, William; Gillor, Daniel; Moreno Macias, Laura; DuVal, Anna; Rothman, Richard; Dugas, Andrea; Guerrero, M Lourdes.
Afiliación
  • Powers JH; Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc., NCI Campus at Frederick, Frederick, MD, United States of America.
  • Bacci ED; Evidera Evidence, Value & Access by PPD, Seattle, WA, United States of America.
  • Leidy NK; Evidera Evidence, Value & Access by PPD, Bethesda, MD, United States of America.
  • Poon JL; Evidera Evidence, Value & Access by PPD, Bethesda, MD, United States of America.
  • Stringer S; Evidera Evidence, Value & Access by PPD, Bethesda, MD, United States of America.
  • Memoli MJ; National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America.
  • Han A; National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, MD, United States of America.
  • Fairchok MP; Madigan Army Medical Center, Fort Lewis, WA, United States of America.
  • Coles C; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.
  • Owens J; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
  • Chen WJ; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.
  • Arnold JC; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
  • Danaher PJ; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.
  • Lalani T; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
  • Burgess TH; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.
  • Millar EV; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
  • Ridore M; Naval Medical Center, San Diego, CA, United States of America.
  • Hernández A; Defense Institute for Medical Operations, San Antonio, TX, United States of America.
  • Rodríguez-Zulueta P; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
  • Ortega-Gallegos H; Naval Medical Center, Portsmouth, VA, United States of America.
  • Galindo-Fraga A; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.
  • Ruiz-Palacios GM; Walter Reed National Military Medical Center, Bethesda, MD, United States of America.
  • Pett S; Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University, Bethesda, MD, United States of America.
  • Fischer W; Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, MD, United States of America.
  • Gillor D; Children's National Medical Center, Washington, DC, United States of America.
  • Moreno Macias L; Instituto Nacional de Enfermedades Infecciosas, Mexico City, Mexico.
  • DuVal A; Hospital General Dr. Manuel Gea González, Mexico City, Mexico.
  • Rothman R; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Dugas A; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Guerrero ML; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
PLoS One ; 13(3): e0194180, 2018.
Article en En | MEDLINE | ID: mdl-29566007
ABSTRACT

BACKGROUND:

The inFLUenza Patient Reported Outcome (FLU-PRO) measure is a daily diary assessing signs/symptoms of influenza across six body systems Nose, Throat, Eyes, Chest/Respiratory, Gastrointestinal, Body/Systemic, developed and tested in adults with influenza.

OBJECTIVES:

This study tested the reliability, validity, and responsiveness of FLU-PRO scores in adults with influenza-like illness (ILI).

METHODS:

Data from the prospective, observational study used to develop and test the FLU-PRO in influenza virus positive patients were analyzed. Adults (≥18 years) presenting with influenza symptoms in outpatient settings in the US, UK, Mexico, and South America were enrolled, tested for influenza virus, and asked to complete the 37-item draft FLU-PRO daily for up to 14-days. Analyses were performed on data from patients testing negative. Reliability of the final, 32-item FLU-PRO was estimated using Cronbach's alpha (α; Day 1) and intraclass correlation coefficients (ICC; 2-day reproducibility). Convergent and known-groups validity were assessed using patient global assessments of influenza severity (PGA). Patient report of return to usual health was used to assess responsiveness (Day 1-7).

RESULTS:

The analytical sample included 220 ILI patients (mean age = 39.3, 64.1% female, 88.6% white). Sixty-one (28%) were hospitalized at some point in their illness. Internal consistency reliability (α) of FLU-PRO Total score was 0.90 and ranged from 0.72-0.86 for domain scores. Reproducibility (Day 1-2) was 0.64 for Total, ranging from 0.46-0.78 for domain scores. Day 1 FLU-PRO scores correlated (≥0.30) with the PGA (except Gastrointestinal) and were significantly different across PGA severity groups (Total F = 81.7, p<0.001; subscales F = 6.9-62.2; p<0.01). Mean score improvements Day 1-7 were significantly greater in patients reporting return to usual health compared with those who did not (p<0.05, Total and subscales, except Gastrointestinal and Eyes).

CONCLUSIONS:

Results suggest FLU-PRO scores are reliable, valid, and responsive in adults with influenza-like illness.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Registros Médicos / Gripe Humana / Autoinforme Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Registros Médicos / Gripe Humana / Autoinforme Tipo de estudio: Clinical_trials / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos